Post-Injury Buprenorphine Administration Is Associated with Long-Term Region-Specific Glial Alterations in Rats

Area of Science:

• Neuroscience
• Traumatic Brain Injury Research
• Pharmacology

Background:

• Traumatic brain injury (TBI) is a significant cause of death and disability.
• Limited research exists on the long-term effects of analgesics, like buprenorphine (Bup), on TBI pathology.
• Previous studies explored acute Buprenorphine-sustained release-Lab (Bup-SR-Lab) effects; this study examines chronic outcomes.

Purpose of the Study:

• To investigate the chronic (4-week) effects of Bup-SR-Lab treatment on TBI outcomes in a rat model.
• To assess the impact of Bup-SR-Lab on histology, neuroinflammation, cell damage, and somatosensory sensitivity post-TBI.
• To determine region-specific and injury-specific alterations induced by Bup-SR-Lab treatment.

Main Methods:

• Adult male rats received central fluid percussion injury (cFPI) and were treated with saline or Bup-SR-Lab.
• Histological assessments included neuronal damage, cytokine expression (IL-4), glial morphology (microglia, astrocytes), and myelin integrity.
• The Whisker Nuisance Task (WNT) evaluated somatosensory sensitivity pre- and post-injury.

Main Results:

• Bup-SR-Lab treatment showed no significant effect on overall physiology, neuronal damage, or somatosensory sensitivity at 4 weeks post-TBI.
• Elevated IL-4 cytokine expression was observed in Bup-SR-Lab treated animals compared to saline controls.
• Region-specific alterations in microglia (cortical) and astrocytes (thalamic) morphology were noted, along with changes in myelin integrity and MBP isoform expression.

Conclusions:

• Bup-SR-Lab treatment does not worsen overall TBI pathology or sensory deficits at 4 weeks.
• Bup-SR-Lab can influence glial cell morphology and myelin in a region-specific manner following diffuse TBI.
• These findings highlight potential long-term, localized impacts of Bup-SR-Lab on TBI-induced glial changes.